EUVIMEDEUVIMED entdecken
Crossref

New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR ‐related metabolic syndrome

Saroj Choudhary iD, Eleanor D Muise, Soumia Hammouda, Danielle Goetz iD, Robert Giusti

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.27160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Saroj Choudhary und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Pediatrics, New York University Langone Hospital-Long Island, Long Island, New York, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Neonatal Screening, Quality Improvement, Metabolic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: This project was supported by a 1-year extension of a Cystic Fibrosis Foundation Screening Improvement Program Award. No conflict of interest declared..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

New York (NY) State implemented a new cystic fibrosis (CF) newborn screen (NBS) algorithm in December 2017 with improvement in positive predictive value and unanticipated increased identification of infants with cystic fibrosis transmembrane conductance regulator ( CFTR )‐related metabolic syndrome (CRMS). Repeat sweat testing is recommended in infants with CRMS. During the COVID‐19 pandemic infants with CRMS were lost to follow up. With this quality improvement (QI) initiative, we aimed to perform repeat sweat testing in 25% of infants lost to follow up. We also describe consensus recommendations for CRMS from the NY CF NBS Consortium.

Methods

Our QI team identified the primary drivers contributing to absent follow up, outreached to families, and created a questionnaire to evaluate parental understanding of CRMS using QI‐based strategies.

Results

Of 350 infants diagnosed with CRMS during the study period, 179 (51.1%) infants were lost to follow up. A total of 31 (17.3%) were scheduled for repeat sweat tests and followed up at CF Centers. Families reported high satisfaction with the CRMS knowledge questionnaire.

Conclusions

With this QI‐based approach, we effectively recaptured infants with CRMS previously lost to follow up during the COVID‐19 pandemic. Ongoing concerns about infection risk and lack of understanding on the part of families and pediatricians likely contributed to patients with CRMS lost to follow up. Consensus recommendations for CRMS include annual visits with repeat sweat testing until 2–6 years of age and education for adolescents about clinical and reproductive implications of CRMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisNeonatal ScreeningQuality ImprovementMetabolic SyndromeCystic Fibrosis Transmembrane Conductance RegulatorCOVID-19HumansInfant, NewbornNew YorkSARS-CoV-2MaleSweatFemaleInfant

Stichwörter der Autor:innen

CFCRMSNBSQIsweat test

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Division of Pulmonary Medicine, Department of Pediatrics, New York University Langone Hospital-Long Island, Long Island, New York, USA.
  • Division of Pulmonary Medicine, Department of Pediatrics, New York University, New York City, New York, USA.
  • Division of Pulmonary Medicine, Department of Pediatrics, University of Buffalo, Buffalo, New York, USA.

ORCID-Profile: Saroj Choudhary, Danielle Goetz

Förderung

  • This project was supported by a 1-year extension of a Cystic Fibrosis Foundation Screening Improvement Program Award. No conflict of interest declared.

Zitieren

APA

Choudhary, S., Muise, E. D., Hammouda, S., Goetz, D., & Giusti, R. (2024). New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR ‐related metabolic syndrome. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27160

Vancouver

Choudhary S, Muise ED, Hammouda S, Goetz D, Giusti R. New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR ‐related metabolic syndrome. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27160

BibTeX
@article{Choudhary2024,
  author = {Choudhary, Saroj and Muise, Eleanor D and Hammouda, Soumia and Goetz, Danielle and Giusti, Robert},
  title = {New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR ‐related metabolic syndrome},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.27160}
}
Kostenlos starten →